Peripheral Arterial Disease in Old People with Diabetes

Diabetes in Old Age: Third Edition

Volumn , Issue , 2009, Pages 39-49

  Mañas, Leocadio Rodríguez ^a   Bouzon, Cristina Alonso ^a   Rodríguez, Marta Castro ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Clinical presentation; Diagnostic methods; Epidemiology of peripheral arterial disease; Pathophysiology; Peripheral arterial disease in old people with diabetes; Vascular complications

Indexed keywords

EID: 84889404793     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470744093.ch4     Document Type: Chapter

References (35)

1. Suarez C, Manzano L, Mostaza J, Cairols M and Palma JC. Prevalence of peripheral artery disease evaluated by ankle brachial index in patients with metabolic syndrome. MERITO I study. Rev Clin Esp. 2007; 207: 228-33.
2. Serrano Hernando FJ and Martín Conejero A. Peripheral artery disease: pathophysiology, diagnosis and treatment. Rev Esp Cardiol 2007; 60: 969-82.
3. Lapolla A, Piarulli F, Sartore G, Ceriello A and Ragazzi E. Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diabetes Care 2007; 30: 670-6.
4. Adler AJ, Boyko EJ, Ahroni JH and Smith DG. Lower extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy and foot ulcers. Diabetes Care 1999; 22: 1029-35.
5. Moss SE, Klein R and Klein BEK. The 14-year incidence of lower-extremity amputations in a diabetic population. Diabetes Care 1999; 22: 951-9.
6. Rodríguez-Mañas L and Monereo Megías S. (2002) El anciano con diabetes. Sociedad Española de Medicina Geriátrica (Spanish Society of Geriatric Medicine)/Sociedad Española de Endocrinología y Nutrición. Villanueva, Madrid.
7. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A and Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998, 18:185-92.
8. Criqui MH, Fronek A, Barret-Connor E, Klauber MR, Gabriel S and Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985, 71:510-15.
9. McDermott MM, Ferrucci L, Simonsick EM, Balfour J, Fried L, Ling S, Gibson D and Guralnik JM. The ankle brachial index and change in lower extremity functioning over time: the Women's Health and Aging Study. J Am Geriatr Soc 2002; 50 : 238-46.
10. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D and Martin GJ. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001, 286:1599-606.
11. Doland NC, Liu K, Criqui MH, Greenland P, Guralnik JM, Chan C, Schneider JR, Mandapat AL, Martin G and McDermott MM. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002, 25: 113-20.
12. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, Pearce WH, Schneider JR, Ferrucci L, Celic L, Taylor LM, Vonesh E, Martin GJ and Clark E. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004, 292:453-61.
13. Long TH, Criqui MH, Vasilevskis EE, Denenberg JO, Klauber MR and Fronek A. The correlation between the severity of peripheral arterial disease and carotid occlusive disease. Vasc Med 1999; 4: 135-42.
14. Criqui MH and Denenberg JO. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 1998, 3:241-5.
15. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery. Circulation 2006, 113: e463-e654.
16. Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM and Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006, 113:2623-9.
17. Schmieder FA and Comerota AJ. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Am J Cardiol 2001, 87: 3D-13D.
18. White, C. Intermittent claudication. N Engl J Med 2007; 356: 1241-50.
19. European Diabetes Working Party for Older People. (2004) Clinical guidelines for Type 2 Diabetes Mellitus. www.eugms.org/index.php?pid=30 (accessed 6 December 2008).
20. Lijmer JG, Hunink MG, van den Dungen JJ, Loonstra J and Smit AJ. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 1996, 22:391-8.
21. Feigelson HS, Criqui MH, Fronek A, Langer RD and Molgaard CA. Screening for peripheral arterial disease: the sensitivity, specificity and predictive value of non-invasive tests in a defined population. Am J Epidemiol 1994, 140: 526-34.
22. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO and Wolfson SK. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation 1993, 88:837-45.
23. Newman AB, Sutton-Tyrrel K, Vogt MT and Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993, 270: 487-9.
24. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003, 26: 3333-41.
25. Plank J, Haas W, Rakovac I, Gorzer E, Sommer R, Siebenhofer A and Pieber TR. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care 2003, 26:1691-5.
26. Reiber GE, Smith DG, Wallace C, Sullivan K, Hayes S, Vath C, Maciejewski ML, Yu O, Heagerty PJ and LeMaster J. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA 2002, 287: 2552-8.
27. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. Br Med J 2002, 324: 71-86.
28. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348: 1329-39.
29. Leng GC, Fowler B and Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev, 2000: CD000990.
30. Bendermacher BL, Willigendael EM, Teijink JA and Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev, 2006: CD005263.
31. Strandness DE, Jr, Dalman RL, Panian S, Rendell MS, Comp PC, Zhang P and Forbes WP. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg 2002, 36:83-91.
32. Nevskaya T, Ananieva L, Bykovskaia S, Eremin I, Karandashov E, Khrennikov J, Mach E, Zaprjagaeva M, Guseva N and Nassonov E. Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis. Rheumatology 2009; 48 (1): 61-4.
33. Werner N and Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med. 2006; 10 (2): 318-32.
34. Versari D, Lerman LO and Lerman A. The importance of reendothelialization after arterial injury. Curr Pharm Des. 2007; 13 (17): 1811-24.
35. Kiernan TJ, Yan BP, Cruz-Gonzalez I, Cubeddu RJ, Caldera A, Kiernan GD and Gupta V. Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting. Cardiovasc Hematol Agents Med Chem. 2008; 6 (2): 116-24.